Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$226.78 USD
-0.77 (-0.34%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $226.58 -0.20 (-0.09%) 5:50 PM ET
3-Hold of 5 3
C Value C Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: BMO |
3/2024 | $2.05 | 0.00% |
Earnings Summary
For their last quarter, Charles River Laboratories International (CRL) reported earnings of $2.46 per share, beating the Zacks Consensus Estimate of $2.39 per share. This reflects a positive earnings surprise of 2.93%. Look out for CRL's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of $2.05 per share, reflecting a year-over-year decrease of 26.26%.
Earnings History
Price & Consensus
Zacks News for CRL
ICLR or CRL: Which Is the Better Value Stock Right Now?
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services